Abstract
This year is the 20th anniversary of the first successful trial of exogenous surfactant for respiratory distress syndrome in the newborn and it is perhaps a good time to review recent advances in basic science and clinical practice as they relate to surfactant therapy.
MeSH terms
-
Animals
-
Glycoproteins / deficiency
-
Glycoproteins / physiology
-
Humans
-
Infant, Newborn
-
Infant, Premature
-
Lung Diseases / drug therapy
-
Mice
-
Mice, Transgenic
-
Proteolipids / physiology
-
Pulmonary Surfactant-Associated Protein D
-
Pulmonary Surfactant-Associated Proteins
-
Pulmonary Surfactants / deficiency
-
Pulmonary Surfactants / physiology
-
Pulmonary Surfactants / therapeutic use*
-
Recombinant Proteins / therapeutic use
-
Respiratory Distress Syndrome, Newborn / drug therapy
Substances
-
Glycoproteins
-
Proteolipids
-
Pulmonary Surfactant-Associated Protein D
-
Pulmonary Surfactant-Associated Proteins
-
Pulmonary Surfactants
-
Recombinant Proteins